135
staff
Christopher Austin
Christopher Austin, MD, is a CEO-partner at Flagship Pioneering in Cambridge, MA, and CEO of Vesa
lius Therapeutics, one of Flagship’s franchise companies that is commercializing a platform to systematically develop treatments for common diseases.
+ Read More
staff
Janet Woodcock
Janet Woodcock, MD, was named acting commissioner of food and drugs on January 20, 2021.
staff
Richard Moscicki
Richard (Rich) A. Moscicki, MD, is the executive vice president for science and regulatory advoca
cy and the chief medical officer at Pharmaceutical Research and Manufacturers of America (PhRMA).
+ Read More
staff
Mohit Joshi
Mohit Joshi is a President of the company.
staff
Lou Maiuri
Lou Maiuri is Chief Operating Officer for State Street Corporation. In this role, he is responsib
le for our IT, Global Delivery, Charles River Development (CRD), State Street Global Exchange and Global Markets organizations.
+ Read More
staff
Madeleine Dassule
report
Envisioning a Trusted System for Health Data Accelerating Medical Research
Technological innovation in the health landscape is occurring rapidly, and much of it would not be
possible without patient data.
+ Read More
report
Future of Work: Insights for 2021 and Beyond
The COVID-19 pandemic has been a double-whammy for inequality: The worst-off have been hit hardest
while economy-wide digitalization has only exacerbated the skills gap.
+ Read More
report
Better Brain Health through Equity: Addressing Health and Economic Disparities in Dementia for African Americans and Latinos
'Better Brain Health through Equity: Addressing Health and Economic Disparities in Dementia for Afr
ican Americans and Latinos' centers around two overarching themes: (1) Strengthening the infrastructure among health-care, long-term care, and community-b
+ Read More
report
Best Practices of Sovereign Wealth Funds: The Case for The Philippines
Many nations create sovereign wealth funds (SWFs) to invest surplus assets in a diversified portfol
io approach to achieve national policy goals, hedge against economic risk, and benefit successive generations.
+ Read More
report
Our Shared Responsibility: Technologies Accelerating the Path to Green Financing
In a private roundtable at the 2022 Singapore Fintech Festival, leading technologists, chief sustai
nability officers, large investors, and financial regulators gathered for off-the-record dis
+ Read More
panel
Lessons Learned from COVID-19: Are There Silver Linings for Biomedical Innovation?
While the response to the COVID-19 pandemic has exposed many of the fault lines in the biomedica
l innovation ecosystem that have slowed progress for decades, we have also shown ourselves capable of innovating in ways we perhaps did not think possible.
+ Read More